{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T15:15:07Z","timestamp":1726067707791},"publisher-location":"New York, NY","reference-count":26,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071603765"},{"type":"electronic","value":"9781071603772"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-1-0716-0377-2_22","type":"book-chapter","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T15:03:02Z","timestamp":1581606182000},"page":"295-305","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Radiotherapy for Cervical Esophageal Squamous Cell Carcinoma"],"prefix":"10.1007","author":[{"given":"Dora L. W.","family":"Kwong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy W. L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ka On","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hed.23678","volume":"37","author":"GD Grass","year":"2015","unstructured":"Grass GD, Cooper SL, Armeson K, Garrett-Mayer E, Sharma A (2015) Cervical esophageal cancer: a population-based study. Head Neck 37:808\u2013814","journal-title":"Head Neck"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/jso.20795","volume":"96","author":"H Daiko","year":"2007","unstructured":"Daiko H, Hayashi R, Saikawa M, Sakuraba M, Yamazaki M, Miyazaki M, Ugumori T, Asai M, Oyama W, Ebihara S (2007) Surgical management of carcinoma of the cervical esophagus. J Surg Oncol 96:166\u2013172","journal-title":"J Surg Oncol"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1093\/annonc\/mdw183","volume":"27","author":"A Hoeben","year":"2016","unstructured":"Hoeben A, Polak J, Van De Voorde L, Hoebers F, Grabsch HI, de Vos-Geelen J (2016) Cervical esophageal cancer: a gap in cancer knowledge. Ann Oncol 27:1664\u20131674","journal-title":"Ann Oncol"},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jamaoto.2014.2013","volume":"140","author":"CN Cao","year":"2014","unstructured":"Cao CN, Luo JW, Gao L, Xu GZ, Yi JL, Huang XD, Li SY, Xiao JP, Liu SY, Xu ZG, Tang PZ (2014) Primary radiotherapy compared with primary surgery in cervical esophageal cancer. JAMA Otolaryngol Head Neck Surg 140:918\u2013926","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1001\/jama.281.17.1623","volume":"281","author":"JS Cooper","year":"1999","unstructured":"Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, Asbell SO, Graham MV, Leichman LL (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281:1623\u20131627","journal-title":"JAMA"},{"key":"22_CR6","first-page":"45","volume":"4","author":"LA Kachnic","year":"2001","unstructured":"Kachnic LA, Winter K, Wasserman T, Kelsen D, Ginsberg R, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Willett CG, Minsky BD (2001) Longitudinal quality-of-life analysis of RTOG 94-05 (Int 0123):a phase III trial of definitive chemoradiotherapy for esophageal cancer. Gastrointest Cancer Res 4:45\u201352","journal-title":"Gastrointest Cancer Res"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ijrobp.2007.10.022","volume":"71","author":"SH Huang","year":"2008","unstructured":"Huang SH, Lockwood G, Brierley J, Cummings B, Kim J, Wong R, Bayley A, Ringash J (2008) Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Radiat Oncol Biol Phys 71:735\u2013740","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1586\/14737140.2015.1074041","volume":"15","author":"T Song","year":"2015","unstructured":"Song T, Liang X, Fang M, Wu S (2015) High-dose versus conventional-dose irradiation in cisplatin-based definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and pooled analysis. Expert Rev Anticancer Ther 15:1157\u20131169","journal-title":"Expert Rev Anticancer Ther"},{"key":"22_CR9","doi-asserted-by":"crossref","first-page":"89095","DOI":"10.18632\/oncotarget.18760","volume":"8","author":"Y Chen","year":"2017","unstructured":"Chen Y, Zhu HP, Wang T, Sun CJ, Ge XL, Min LF, Zhang XW, Jia QQ, Yu J, Yang JQ, Allgayer H, Abba ML, Zhang XZ, Sun XC (2017) What is the optimal radiation dose for non-operable esophageal cancer? Dissecting the evidence in a meta-analysis. Oncotarget 8:89095\u201389107","journal-title":"Oncotarget"},{"key":"22_CR10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/hed.25483","volume":"41","author":"TH Kim","year":"2019","unstructured":"Kim TH, Lee IJ, Kim JH, Lee CG, Lee YC, Kim JW (2019) High-dose versus standard-dose radiation therapy for cervical esophageal cancer: retrospective single-institution study. Head Neck 41:146\u2013153","journal-title":"Head Neck"},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.radonc.2015.07.011","volume":"116","author":"P Zhang","year":"2015","unstructured":"Zhang P, Xi M, Zhao L, Qiu B, Liu H, Hu YH, Liu MZ (2015) Clinical efficacy and failure pattern in patients with cervical esophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol 116:257\u2013261","journal-title":"Radiother Oncol"},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00405-015-3576-y","volume":"273","author":"CN Cao","year":"2016","unstructured":"Cao CN, Luo JW, Gao L, Xu GZ, Yi JL, Huang XD, Wang K, Zhang SP, Qu Y, Li SY, Xiao JP, Zhang Z (2016) Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma: clinical outcomes and patterns of failure. Eur Arch Otorhinolaryngol 273:741\u2013747","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ijrobp.2017.01.003","volume":"98","author":"LJ McDowell","year":"2017","unstructured":"McDowell LJ, Huang SH, Xu W, Che J, Wong RKS, Brierley J, Kim J, Cummings B, Waldron J, Bayley A, Hansen A, Witterick I, Ringash J (2017) Effect of intensity modulated radiation therapy with concurrent chemotherapy on survival for patients with cervical esophageal carcinoma. Int J Radiat Oncol Biol Phys 98:186\u2013195","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"22_CR14","first-page":"1","volume":"31","author":"HX Li","year":"2018","unstructured":"Li HX, Liu J, Cheng Y, Liu MN, Fang WT, Lv CX (2018) Concurrent chemoradiotherapy for cervical esophageal squamous cell carcinoma: treatment results from a prospective observational study. Dis Esophagus 31:1\u20136","journal-title":"Dis Esophagus"},{"key":"22_CR15","doi-asserted-by":"crossref","first-page":"21852","DOI":"10.18632\/oncotarget.15665","volume":"8","author":"L Zhao","year":"2017","unstructured":"Zhao L, Zhou Y, Mu Y, Chai G, Xiao F, Tan L, Lin SH, Shi M (2017) Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer. Oncotarget 8:21852\u201321860","journal-title":"Oncotarget"},{"key":"22_CR16","first-page":"5039","volume":"37","author":"A Kumabe","year":"2017","unstructured":"Kumabe A, Zenda S, Motegi A, Onozawa M, Nakamura N, Kojima T, Daiko H, Shigematsu N, Akimoto T (2017) Long-term clinical results of concurrent chemoradiotherapy for patients with cervical esophageal squamous cell carcinoma. Anticancer Res 37:5039\u20135044","journal-title":"Anticancer Res"},{"key":"22_CR17","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1002\/hed.24909","volume":"39","author":"M Ito","year":"2017","unstructured":"Ito M, Kodaira T, Tachibana H, Tomita N, Makita C, Koide Y, Kato D, Abe T, Muro K, Tajika M, Niwa Y, Hasegawa Y (2017) Clinical results of definitive chemoradiotherapy for cervical esophageal cancer: comparison of failure pattern and toxicities between intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy. Head Neck 39:2406\u20132415","journal-title":"Head Neck"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10388-018-0627-7","volume":"15","author":"H Okamoto","year":"2018","unstructured":"Okamoto H, Taniyama Y, Sakurai T, Heishi T, Teshima J, Sato C, Maruyama S, Ito K, Onodera Y, Konno-Kumagai T, Ishida H, Kamei T (2018) Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer. Esophagus 15:281\u2013285","journal-title":"Esophagus"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13014-018-0957-6","volume":"13","author":"K Sakanaka","year":"2018","unstructured":"Sakanaka K, Ishida Y, Fujii K, Itasaka S, Miyamoto S, Horimatsu T, Muto M, Mizowaki T (2018) Long-term outcome of definitive radiotherapy for cervical esophageal squamous cell carcinoma. Radiat Oncol 13:7","journal-title":"Radiat Oncol"},{"key":"22_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.oraloncology.2018.09.026","volume":"86","author":"ME Spector","year":"2018","unstructured":"Spector ME, Rosko AJ, Swiecicki PL, Chad Brenner J, Birkeland AC (2018) From VA larynx to the future of chemoselection: defining the role of induction chemotherapy in larynx cancer. Oral Oncol 86:200\u2013205","journal-title":"Oral Oncol"},{"key":"22_CR21","first-page":"1989","volume":"34","author":"G Suzuki","year":"2014","unstructured":"Suzuki G, Yamazaki H, Ogo E, Abe T, Eto H, Muraki K, Hattori C, Umeno H, Nakashima T, Tanaka T, Nakamura S, Yoshida K (2014) Multimodal approach for cervical esophageal carcinoma: role of neoadjuvant chemotherapy. Anticancer Res 34:1989\u20131992","journal-title":"Anticancer Res"},{"key":"22_CR22","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/s10147-017-1149-3","volume":"22","author":"Y Nakata","year":"2017","unstructured":"Nakata Y, Hanai N, Nishikawa D, Suzuki H, Koide Y, Fukuda Y, Nomura M, Kodaira T, Shimizu T, Hasegawa Y (2017) Comparison between chemoselection and definitive radiotherapy in patients with cervical esophageal squamous cell carcinoma. Int J Clin Oncol 22:1034\u20131041","journal-title":"Int J Clin Oncol"},{"key":"22_CR23","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1200\/JCO.2012.47.7802","volume":"31","author":"P Blanchard","year":"2013","unstructured":"Blanchard P, Bourhis J, Lacas B, Posner MR, Vermorken JB, Cruz Hernandez JJ, Bourredjem A, Calais G, Paccagnella A, Hitt R, Pignon JP, Meta-Analysis of Chemotherapy in Head and Neck Cancer, Induction Project, Collaborative Group (2013) Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. J Clin Oncol 31:2854\u20132860","journal-title":"J Clin Oncol"},{"key":"22_CR24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/dote.12362","volume":"29","author":"Y Niwa","year":"2016","unstructured":"Niwa Y, Koike M, Fujimoto Y, Oya H, Iwata N, Nishio N, Hiramatsu M, Kanda M, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Nomoto S, Fujiwara M, Kodera Y (2016) Salvage pharyngolaryngectomy with total esophagectomy following definitive chemoradiotherapy. Dis Esophagus 29:598\u2013602","journal-title":"Dis Esophagus"},{"key":"22_CR25","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.oraloncology.2011.05.002","volume":"47","author":"JK Salama","year":"2011","unstructured":"Expert Panel on Radiation Oncology-Head and Neck, Salama JK, Saba N, Quon H, Garg MK, Lawson J, MW MD, Ridge JA, Smith RV, Yeung AR, Yom SS, Beitler JJ (2011) ACR appropriateness criteria\u00ae adjuvant therapy for resected squamous cell carcinoma of the head and neck. Oral Oncol 47:554\u2013559","journal-title":"Oral Oncol"},{"key":"22_CR26","doi-asserted-by":"crossref","first-page":"32220","DOI":"10.18632\/oncotarget.4730","volume":"6","author":"Q Liu","year":"2015","unstructured":"Liu Q, Cai XW, Fu XL, Chen JC, Xiang JQ (2015) Tolerance and dose-volume relationship of intrathoracic stomach irradiation after esophagectomy for patients with thoracic esophageal squamous cell carcinoma. Oncotarget 6:32220\u201332227","journal-title":"Oncotarget"}],"container-title":["Methods in Molecular Biology","Esophageal Squamous Cell Carcinoma"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-0377-2_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T20:57:45Z","timestamp":1695761865000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-0716-0377-2_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9781071603765","9781071603772"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-0377-2_22","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"14 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}